Mar 20 |
Fusion Pharmaceuticals GAAP EPS of -$0.39 misses by $0.06
|
Mar 20 |
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
|
Mar 20 |
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
|
Mar 20 |
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
|
Mar 19 |
Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover
|
Mar 19 |
Stocks to Watch Tuesday: Super Micro, Fusion Pharmaceuticals, Nvidia, Unilever
|
Mar 19 |
What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals
|
Mar 19 |
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
|
Mar 19 |
These Stocks Are Moving the Most Today
|
Mar 19 |
Super Micro, XPeng, AstraZeneca: Trending tickers
|